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The regulation of neutrophil lifespan by induction of apoptosis is critical for maintaining an effective host 
response and preventing excessive inflammation. The hypoxia-inducible factor (HIF) oxygen-sensing pathway 
has a major effect on the susceptibility of neutrophils to apoptosis, with a marked delay in cell death observed 
under hypoxic conditions. HIF expression and transcriptional activity are regulated by the oxygen-sensitive 
prolyl hydroxylases (PHD1–3), but the role of PHDs in neutrophil survival is unclear. We examined PHD 
expression in human neutrophils and found that PHD3 was strongly induced in response to hypoxia and 
inflammatory stimuli in vitro and in vivo. Using neutrophils from mice deficient in Phd3, we demonstrated 
a unique role for Phd3 in prolonging neutrophil survival during hypoxia, distinct from other hypoxia-associ-
ated changes in neutrophil function and metabolic activity. Moreover, this selective defect in neutrophil sur-
vival occurred in the presence of preserved HIF transcriptional activity but was associated with upregulation of 
the proapoptotic mediator Siva1 and loss of its binding target Bcl-xL. In vivo, using an acute lung injury model, 
we observed increased levels of neutrophil apoptosis and clearance in Phd3-deficient mice compared with WT 
controls. We also observed reduced neutrophilic inflammation in an acute mouse model of colitis. These data 
support what we believe to be a novel function for PHD3 in regulating neutrophil survival in hypoxia and may 
enable the development of new therapeutics for inflammatory disease.
Introduction
Therapeutic agents that selectively limit neutrophil lifespan during 
inflammation are a major unmet medical need, since persistent and 
inappropriate activation of neutrophils is central to the pathogen-
esis of a number of inflammatory diseases. In contrast, neutropenia 
and defective neutrophil function are associated with catastrophic 
impairment of host defense. A fine balance exists therefore between 
the requirement for fully competent neutrophils at the onset of the 
inflammatory response and the need for their prompt deactivation 
and/or removal to limit tissue damage. Neutrophil apoptosis is rec-
ognized as a major mechanism for the clearance of effete neutrophils 
from inflammatory foci, and, in vivo, acceleration of neutrophil 
apoptosis enhances resolution of neutrophilic inflammation (1). 
Since many proinflammatory mediators inhibit neutrophil apop-
tosis, the selective removal of these cells, after they have discharged 
their phagocytic and bactericidal functions, represents an attrac-
tive antiinflammatory strategy, with the potential to limit the side 
effects associated with existing antiinflammatory drugs while pre-
serving basal host defense functions.
A key regulator of neutrophil apoptosis is the HIF-1α subunit 
of the oxygen-sensitive transcription factor hypoxia-inducible fac-
tor (HIF) (2). HIF effector genes increase tissue oxygen delivery and 
adaptation to anaerobic metabolism in all cell types (3). In myeloid 
cells, HIF-1α deficiency reduces cell aggregation, motility, invasive-
ness, and bacterial killing (4). HIF therefore regulates many aspects 
of the adaptive response of neutrophils to hypoxia during inflam-
mation and, uniquely among nontransformed cells, extends neu-
trophil lifespan by delay of apoptosis (2). HIF also regulates myeloid 
responses to proinflammatory stimuli (5, 6) with a critical role in the 
neutrophil’s ability to phagocytose and kill bacteria even under nor-
moxic conditions. Therefore, direct targeting of HIF may lack the 
precision required of novel treatments for inflammatory disease.
The HIF-α subunit is regulated by hydroxylation, both by a fam-
ily of proyl hydroxylase domain–containing enzymes (PHDs, also 
known as EGL-N1-3; refs. 7, 8), leading to ubiquitination and pro-
teasomal degradation, and by transcriptional inactivation follow-
ing asparaginyl hydroxylation by factor inhibiting HIF (FIH) (9). 
The enzymatic function of PHDs and FIH is believed to be criti-
cal for inhibition of HIF transcriptional activity in vivo (9–12). To 
date, 4 PHD proteins with HIF hydroxylation activity have been 
described (PHD1, PHD2, PHD3, and P4H-TM) with wide but var-
ied tissue expression (13, 14). While PHD enzymes are major regu-
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lators of HIF activity, there is also increasing evidence of roles for 
individual PHDs in regulating cellular processes independently of 
HIF-1 interactions (11, 12, 15–17).
Since HIF has such an important role in neutrophil survival, we pro-
posed that PHD enzymes are fundamentally involved in this process. 
More specifically, given our original description of hypoxia-mediated 
neutrophil survival (18, 19), the previously described hypoxic induc-
tion of PHD2 and PHD3 by HIF, and our initial observation of selec-
tive regulation of PHD3 by neutrophil hypoxia, aging, TLR agonists, 
and chronic inflammatory disease, we hypothesized that PHD3 may 
be an important regulator of neutrophil function and fate.
Results
PHD3 is differentially regulated in human neutrophils by pro-survival 
stimuli. Human peripheral blood neutrophils constitutively express 
PHD1, PHD2, and PHD3 pro-
teins (Figure 1A). Neutrophil 
PHD3 protein expression was 
markedly increased by time in 
culture and further increased 
by hypoxic conditions, whereas 
expression of PHD1 and PHD2 
proteins was unaltered (Figure 
1A). Sustained culture in hypoxic 
conditions, at an oxygen tension 
that induced the HIF target gene 
GAPDH in neutrophils, induced 
significantly greater increases 
in PHD3 transcript abundance 
than PHD1 or PHD2 (Figure 
1B). PHD3 transcript was also 
the most responsive to stimu-
lation of neutrophils with the 
NOD agonist peptidoglycan (ref. 
20 and Figure 1C). PHD3 (and 
PHD2) was also significantly 
upregulated in peripheral blood 
neutrophils isolated from indi-
viduals with active rheumatoid 
arthritis (Figure 1D). PHD3 was 
thus inducible both by hypoxia 
and inflammatory stimulation, 
suggesting a role for PHD3 in 
regulating neutrophil function 
and lifespan.
Phd3-null mice have a normal 
peripheral blood phenotype. To 
determine whether Phd3 influ-
ences basal neutrophil numbers 
or function, we studied peripher-
al blood neutrophils from mice 
deficient in Phd3 (21) and com-
pared them with those from WT 
mice. Phd3-deficient animals 
were viable and healthy and had 
normal differential white cell 
counts, and, specifically, nor-
mal numbers of neutrophils. 
Furthermore, they mounted a 
normal peripheral blood neu-
trophil response to zymosan-mediated peritonitis (Supplemental 
Figure 1A; supplemental material available online with this article; 
doi:10.1172/JCI43273DS1).
Phd3–/– neutrophils have preserved function in normoxia and hypoxia. 
Peripheral blood neutrophils isolated from Phd3-null and WT 
mice were used in a panel of assays to investigate the effects of 
Phd3 loss on neutrophil function. Phd3–/– neutrophils migrated 
normally toward the chemokine KC during both normoxia and 
hypoxia (Figure 2A). Likewise, coculture of Phd3–/– or WT neutro-
phils with heat-inactivated E. coli resulted in equivalent uptake of 
bacteria in both normoxia and hypoxia (Figure 2B). The ability of 
Phd3–/– neutrophils to undergo respiratory burst following stimu-
lation with heat-inactivated E. coli was also preserved (Figure 2C). 
Unlike the previously reported effect of HIF-1α deletion in lower-
ing neutrophil intracellular ATP levels (4), we found no significant 
Figure 1
PHD3 is upregulated in human neutrophils in response to hypoxia and proinflammatory stimuli. (A) Expres-
sion of PHD1, -2, and -3. Human peripheral blood PMNs and PBMCs were lysed at time 0 or following 
15 hours (PMNs) or 24 hours (PBMCs) culture in normoxia (N) or hypoxia (H) and then protein separated 
by SDS-PAGE. Blots shown are representative of n = 9 experiments, with p38-MAPK loading controls. 
(B) Induction of PHD3 by hypoxia. Human PMNs were aged for 6 or 12 hours in normoxia (black bars) or 
hypoxia (white bars). TaqMan analysis of cDNA was performed with data normalized to β-ACTIN expres-
sion. Data show fold change with respect to normoxic samples at 6 hours (n = 6). (C) Peptidoglycan 
induces PHD3. Human PMNs were cultured in the presence (white bars) or absence (black bars) of 
peptidoglycan (10 μg/ml) for 3 or 5 hours. TaqMan analysis of cDNA was performed with data normalized 
to β-ACTIN. Data shown represent fold change with respect to normoxic samples at 3 hours (n = 5). (D) 
PMNs from patients with rheumatoid arthritis show increased PHD2 and PHD3 transcript levels. TaqMan 
analysis of cDNA from freshly isolated peripheral blood PMNs of 6 healthy controls (squares) and 6 indi-
viduals with active rheumatoid arthritis (triangles) normalized to β-ACTIN. Significant P values only are 
shown for healthy compared with rheumatoid neutrophil expression.
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differences in either intracellular glucose or ATP concentration in 
Phd3–/– versus WT neutrophils (Supplemental Figure 1, B and C).
Loss of Phd3 results in a selective loss of hypoxic neutrophil survival. 
We next determined the role of Phd3 in neutrophil pro-survival 
pathways. Neutrophils were cultured in the presence or absence 
of known survival stimuli and rates of apoptosis determined. In 
keeping with multiple studies of human neutrophils, murine neu-
trophils underwent constitutive apoptosis, but at a slightly faster 
rate, with 20%–30% of WT neutrophils apoptotic at 6 hours and 
60%–80% at 12 hours (Figure 3, A–C). WT and Phd3–/– neutrophils 
Figure 2
Phd3–/– neutrophils function normally in vitro. Murine peripheral blood PMNs from WT (white bars) and Phd3–/– (black bars) animals were stud-
ied. (A) Chemotaxis toward 0–1 μM KC was equivalent in normoxic and hypoxic conditions (n = 4). (B) Phagocytosis. The percentage of PMNs 
ingesting heat-inactivated Alexa Fluor 488–labeled E. coli (MOI of 1:1) was determined by flow cytometry (n = 3). (C) Respiratory burst. PMNs 
were preincubated in normoxia or hypoxia; DCF was added, then heat inactivated E. coli (MOI of 10:1 E. coli/neutrophil). Change in DCF emis-
sion was determined by flow cytometry. Data represent fold change in geometric mean fluorescence from DCF-only controls (n = 5).
Figure 3
Selective loss of hypoxic survival in Phd3–/– neutrophils. Murine peripheral blood PMNs were isolated from WT (white bars), Phd3–/– (black bars), 
and Hif1a–/– (gray bars) animals. Representative cytospins are shown, with apoptotic cells highlighted by arrowheads and apoptosis assessed by 
morphology (A–C) (original magnification, ×1,000). (A) LPS-mediated survival. PMNs were cultured in the presence/absence of LPS (100 ng/ml) 
for 6 or 12 hours (n = 4). (B and C) PMNs from WT, Phd3–/–, and Hif1a–/– animals were cultured in normoxia or hypoxia for 6 or 12 hours (n = 4).
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showed a similar survival response to the TLR4 agonist LPS, equiv-
alent to that of human neutrophils (ref. 22 and Figure 3A). Hypox-
ia also prolonged WT neutrophil survival, again as in human neu-
trophils (18, 19), but this survival response was completely absent 
in Phd3–/– neutrophils (Figure 3B). The observed loss of survival 
mirrors the loss of hypoxic survival we previously reported in 
bone marrow–derived Hif1a–/– neutrophils (2) and now confirm 
in peripheral blood neutrophils from these animals (Figure 3C). 
The morphological phenotype of loss of hypoxic neutrophil sur-
vival in Phd3–/– neutrophils was verified by two biochemical assays, 
which demonstrated increases in both annexin V/TO-PRO-3 
positivity and caspase activity, as 
determined by increased cleavage of 
the synthetic caspase substrate FITC-
VAD (Supplemental Figure 2).
Since Phd3-mediated effects on 
cell survival may be Hif-2α or Hif-1α 
dependent (21), we sought but found 
no evidence of altered Hif1a or Hif2a 
transcriptional upregulation of tar-
get genes in Phd3–/– neutrophils. 
Glut1 (Supplemental Figure 3A) and 
Gapdh (Supplemental Figure 3B) 
were upregulated to a similar extent 
in WT and Phd3–/– neutrophils fol-
lowing hypoxic stimulation. Of note, 
we saw no compensatory change in 
expression of other PHD isoforms 
in neutrophils isolated from the 
Phd3–/– mice (Supplemental Figure 
3C). Hif1a–/– neutrophils showed sig-
nificantly less Phd3 upregulation in 
hypoxia (Supplemental Figure 3D), 
raising the possibility that loss of 
PHD3 specifically impairs hypoxic 
survival in these cells.
PHD3-dependent hypoxic neutrophil 
survival alters expression of Siva1 and 
Bcl-xL. Given the preserved HIF tran-
scriptional responses to hypoxia 
in Phd3–/– neutrophils, a gene array 
approach was undertaken to iden-
tify other regulators of neutrophil 
lifespan that might be altered in 
Phd3–/– cells. Using a whole mouse 
genome Affymetrix array, we com-
pared transcript abundance in WT 
and Phd3–/– neutrophils exposed to 
hypoxia for 4 hours (data available via 
GEO accession number GSE26023). 
In keeping with our previous observa-
tions in human neutrophils, murine 
neutrophils expressed a relatively 
select set of genes (2). We identified 39 
genes that were upregulated (Table 1) 
and 52 genes (excluding replicates) 
downregulated (Supplemental Table 1) 
in Phd3–/– compared with WT neutro-
phils in hypoxia, the gene downregu-
lated to the greatest extent in Phd3–/– 
neutrophils being Phd3 itself. We also identified downregulation of 
Kif-1bβ  a recently described PHD3 target modulating neuronal cell 
apoptosis (11), but KIF-1Bβ protein expression in murine neutrophils 
was not altered by aging or hypoxia (data not shown). A proapoptotic 
factor, Siva1 (23), showed 2.3-fold greater expression in Phd3–/– com-
pared with WT neutrophils (verified by quantitative PCR). WT neu-
trophils cultured in vitro showed reduced SIVA1 protein in hypoxia 
compared with normoxia, whereas levels were significantly higher 
in Phd3–/– neutrophils (Figure 4A). Intriguingly, we had previously 
shown SIVA1 is downregulated by hypoxia in human peripheral 
blood neutrophils (2). SIVA1 is a proapoptotic protein that binds 
Table 1
Transcripts showing 2-fold or greater increase in abundance in hypoxic Phd3–/– neutrophils  
compared with WT controls
log FC PPLR Gene name
3.925322118 0.999343575 Semaphorin 3 F
3.352421486 0.999999576 Selenium binding protein 1
2.584668671 0.998842652 Kalirin, RhoGEF kinase
2.125858236 0.999976987 Cysteinyl leukotriene receptor 1
1.899844604 0.990069359 Nitric oxide synthase 1, neuronal
1.5119704 0.979990713 Lectin, galactose binding, soluble 7
1.493943116 0.998796069 Budding uninhibited by benzimidazoles 1 homolog (S. cerevisiae)
1.353756117 0.971341408 Siva1, apoptosis-inducing factor
1.34730695 0.993344079 Ankyrin repeat and BTB (POZ) domain containing 1
1.3206522 0.994855977 Spermiogenesis specific transcript on the Y 1
1.274218737 0.992765302 Pecanex homolog (Drosophila)
1.262811932 0.948080097 Growth factor receptor bound protein 2
1.259330575 0.997656664 N-myc downstream regulated gene 1
1.239110039 0.987164993 Eukaryotic translation initiation factor 4E member 2
1.229385576 0.965196019 Mitochondrial ribosomal protein L48
1.227987894 0.986680163 LysM, putative peptidoglycan-binding, domain containing 1
1.174745085 0.996823098 Kelch-like 5 (Drosophila)
1.165229235 0.968078479 Retinoic acid receptor, gamma
1.162960794 0.972785133 Rho GTPase activating protein 9
1.146854945 0.98174402 Spermiogenesis specific transcript on the Y 2
1.146825505 0.995206015 Interferon beta 1, fibroblast
1.143522655 0.972736111 Hippocalcin
1.128351638 0.96145951 RNA binding motif protein, X chromosome
1.11938374 0.966881765 Arp5, actin-related protein 5 homolog (yeast)
1.109596587 0.993556155 N-myc downstream regulated gene 1
1.103177794 0.984453597 Rho GTPase activating protein 9
1.098617545 0.977008031 Zinc finger, ZZ-type with EF hand domain 1
1.06255052 0.990541611 ATPase type 13A3
1.061019326 0.989647195 Development and differentiation enhancing factor 2
1.053652749 0.988146643 R3H domain 1 (binds single-stranded nucleic acids)
1.047100162 0.972633887 Misato homolog 1 (Drosophila)
1.039901469 0.988765942 abl-interactor 2
1.036020811 0.951103587 Ring finger protein 32
1.01438415 0.907725871 Polypyrimidine tract binding protein 1
1.011937488 0.988890872 Calcium/calmodulin-dependent serine protein kinase (Maguk)
1.00411005 0.968062265 Autophagy-related 7 (yeast)
1.003589415 0.92791975 Interferon stimulated exonuclease gene 20-like 1
1.003337454 0.907396915 Dead (Asp-Glu-Ala-Asp) box polypeptide 5
1.000333223 0.991686553 Ubiquitin protein ligase E3C
Gene array (Geo GSE26023). cDNA from WT and Phd3–/– neutrophils aged for 4 hours in hypoxia was 
run on Affymetrix whole mouse gene array chips in n = 3 independent experiments. Individual arrays were 
normalized, and log fold change (log FC) in transcript abundance was determined for Phd3–/– compared 
with WT cells by PANTHER analysis. For each gene, probability of positive log ratio (PPLR; http://www.
bioinf.manchester.ac.uk/resources/puma/pplr/pplr.html) values represent the probability of the estimated 
fold change being close to the determined values. Genes showing a greater than 2-fold increase are listed 
in order of magnitude of response.
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BCL-XL and inhibits BCL-XL–mediated enhancement of cell survival 
(24). BCL-XL is expressed in human neutrophils following inflamma-
tory mediator stimulation in vitro (25) and in exudative neutrophils 
in vivo (26), but the role of BCL-XL in regulating neutrophil apop-
tosis has not been studied. Bcl-xL is upregulated in hypoxia-stimu-
lated WT neutrophils, but this is significantly reduced in Phd3–/– 
cells (Figure 4B). Further confirming the importance of SIVA1 and 
BCL-XL expression in determining neutrophil lifespan, we found 
downregulation of SIVA1 in human neutrophils in hypoxia com-
pared with normoxia (Figure 4C), while the loss of BCL-XL observed 
with time in culture in normoxic cultures did not occur in hypoxia 
(Figure 4D). The dependence of neutrophils on BCL-XL expression 
for hypoxic survival was confirmed using ABT-737, a small molecule 
BH3 mimetic with specificity for BCL-XL, BCL-2, and BCL-W pro-
teins (27), of which only BCL-XL is expressed in neutrophils (25, 26). 
ABT-737 completely abrogated the enhanced survival of neutrophils 
under hypoxia at a concentration that also reversed the survival effect 
of GM-CSF, a pro-survival stimulus known to induce BCL-XL (ref. 
28 and Figure 4E), but was without effect upon constitutive apop-
tosis. In addition a pan-hydroxylase inhibitor, DMOG, previously 
shown to inhibit PHD3 and other dioxygenases (29), mimicked in 
human neutrophils the changes in SIVA1/BCL-XL protein levels seen 
in Phd3–/– compared with WT murine neutrophils (Figure 4F). Col-
lectively, these data establish what we believe to be novel roles for 
SIVA1 and BCL-XL in regulating survival of both murine and human 
neutrophils in hypoxia.
Phd3 mediates hypoxic neutrophil survival in acute lung injury and colitis. 
To investigate the importance of Phd3 in regulating neutrophilic 
inflammation in vivo, we used a well-characterized model of LPS-
induced acute lung injury, which induces rapid neutrophil influx 
to the lungs followed by spontaneous resolution (30). Given the 
selectivity of Phd3 for hypoxic neutrophil survival, this model was 
studied in both hypoxia and normoxia. There were no significant 
differences in bronchoalveolar lavage (BAL) total cell counts, total 
neutrophil counts, morphologically scored neutrophil apoptosis, 
or TUNEL-positive events between WT and Phd3-null mice recov-
ered in normoxia (Figure 5, A–D). However, in ambient hypoxia 
(0.1 FiO2), there was a significant reduction in total cell counts and 
Figure 4
Phd3 modifies Siva1 and Bcl-xL expression. (A and B) Murine peripheral blood neutrophil protein expression. PMNs from WT and Phd3–/– animals 
were aged for 5 hours in normoxia or hypoxia. Total protein was separated by SDS-PAGE and densitometry performed relative to β-actin for 
Phd3–/– (black bars) compared with WT (white bars) lysates in normoxia and hypoxia (n = 6). (C and D) Human peripheral blood neutrophil pro-
tein expression. PMNs were aged for 20 hours in normoxia or hypoxia. Total protein was separated by SDS-PAGE and densitometry performed 
relative to β-actin for normoxia (gray bars) and hypoxia (white bars) (n = 7). (E) BCL-XL mediates human neutrophil survival. PMNs were preincu-
bated with the BH3 mimetic ABT-737 (1–10 μM), then cultured in normoxia (gray bars) with or without GM-CSF (500 U/ml) or hypoxia (white bars) 
for 20 hours, and apoptosis was assessed by morphology (n = 4). (F) The hydroxylase inhibitor DMOG modifies SIVA1 and BCL-XL expression. 
PMNs were aged for 5 hours in normoxia or hypoxia with or without DMOG (100 μM), and total protein was separated by SDS-PAGE.
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neutrophil counts in Phd3-null mice, with a concomitant increase 
in both morphologic neutrophil apoptosis and TUNEL-positive 
events (Figure 5, E–H). This correlated with a reduction in the 
characteristic neutrophil-dominant pulmonary inflammation as 
detailed by histology (Figure 5I). There were no significant differenc-
es in BAL macrophage or lymphocyte counts in WT compared with 
Phd3–/– mice in normoxia or hypoxia. The reduction in total neutro-
phil count was independent of neutrophil recruitment in the first 
6 hours (Figure 5J), a time point at which phenotypic differences in 
neutrophil recruitment are revealed (31, 32). Immunohistochemical 
staining of serial lung sections colocalized myeloperoxi-
dase-stained (MPO-stained) neutrophils with both Bcl-xL 
and Siva1 staining (Figure 5K), although other cell types do also 
express these proteins, in keeping with previous data (33, 34).
Dextran sulfate sodium–induced (DSS-induced) colitis is an in 
vivo model of inflammation where neutrophils are prominent and 
that is associated with a marked degree of tissue hypoxia (35). Using 
the acute 6-day time point, we determined the number of neutro-
phils present in the intestinal mucosa using immunohistochemical 
staining. We observed significantly fewer MPO-positive cells, i.e., 
neutrophils, in the intestinal mucosa of Phd3-null compared with 
WT mice (Figure 6, A and B). In keeping with our observations in 
the lung injury model, the submucosal regions of the bowel, where 
the inflammatory cell infiltrate is mostly seen, displayed fewer 
MPO-positive cells and less intense Bcl-xL staining in Phd3–/– than 
WT sections. Siva1 was expressed at high levels in all sections (Fig-
ure 6B), in keeping with its known tissue expression (34). Examina-
tion of cells at higher power clearly showed that Bcl-xL and Siva1 
Figure 5
Enhanced resolution of neutrophilic inflammation in Phd3–/– animals in hypoxia. (A–I) Acute lung injury was induced by intratracheal LPS 
installation. Six hours after LPS, animals were recovered in environmental normoxia (21%) or hypoxia (10%) for 18 hours. BAL samples were 
assessed for total cell counts (A and E), total neutrophil counts (B and F), percent morphological neutrophil apoptosis (C and G), and percent 
TUNEL-positive PMNs (D and H) in WT (white bars) versus Phd3-null (black bars) mice for both normoxic recovery (A–D) and hypoxic recovery 
(E–H) (n = 9). (I) Animals were sacrificed at 18 hours, lungs fixed with 10% buffered formalin and paraffin-embedded, and sections stained with 
hematoxylin and eosin; original magnification, ×400. (J) Acute lung injury was induced by nebulized LPS and BAL samples assessed at 6 hours 
for total cell and neutrophil differential counts in WT (white bars) versus Phd3-null (black bars) mice (n = 4). (K) Bcl-xL and Siva1 expression by 
inflammatory cells. Serial paraffin-embedded sections from hypoxia-recovered mice were stained for expression of the neutrophil marker MPO, 
Bcl-xL, and Siva1, and individual MPO-positive matched cells are indicated by arrows; original magnification, ×400.
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staining was associated with cells with the morphologic appearance 
of neutrophils (Figure 6C). Apoptosis detection by TUNEL staining 
revealed more frequent apoptotic cells in the inflammatory regions 
of the Phd3–/– compared with the WT sections (Figure 6D). These 
experiments again support an important role for Phd3 in regulat-
ing neutrophil persistence in inflammation.
Discussion
Neutrophilic inflammation typically occurs in extremely hypoxic 
environments, with oxygen tensions close to zero in neutrophilic 
exudates. Hypoxia is a profoundly antiapoptotic stimulus to neu-
trophils (18, 19), an effect that is principally mediated via HIF-1α 
(2). HIF-1 inactivation, however, also results in wider impairment 
of neutrophil host defense functions (4, 5, 6). Since HIF expression 
is regulated by prolyl hydroxylase enzymes, and since PHD2 and -3 
are induced in hypoxia, we proposed PHDs might also regulate 
neutrophil survival at sites of inflammation and hypoxia.
We found human neutrophils express all 3 PHD isoforms consti-
tutively as both mRNA and protein, but importantly only PHD3 
protein was increased by culture in hypoxia. PHD3 transcript 
was induced by both hypoxia and peptidoglycan treatment and 
elevated in patient samples, whereas PHD2 transcript showed a 
relatively modest fold change with hypoxic stimulation, and was 
downregulated by the NOD agonist peptidoglycan. This differ-
ential regulation of PHD2 and PHD3 suggests that individual 
PHDs may have distinct roles in disease pathogenesis and innate 
immune responses. In Phd3-deficient neutrophils, we identified 
a direct and highly specific role for Phd3 in maintaining neutro-
phil survival in hypoxia. Importantly, this hypoxic regulation of 
survival can be dissociated from the delay of apoptosis induced 
by the prototypic proinflammatory mediator LPS. This is particu-
larly interesting given the role of HIF-1α in the development of 
LPS-induced sepsis syndrome (6) and the enhanced production 
of immune-defense molecules in an HIF-1α–dependent fashion 
following macrophage coculture with both Gram-positive and 
-negative pathogens (5), suggesting that the mechanisms invoked 
in PHD3-dependent regulation of hypoxic neutrophil survival are 
more selective and complex than a simple feedback into regula-
tion of HIF signaling pathways. This is further supported by the 
phenotypic divergence between Phd3-null and Hif1a-null neutro-
Figure 6
Reduced neutrophilic inflammation in Phd3–/– animals in colitis. Six days following DSS diet-induced colitis, colonic sections from WT (white bars), 
and Phd3–/– (black bars) mice were harvested and fixed in paraffin, and sections were stained with anti-MPO, anti–Bcl-xL, or anti-Siva1 antibodies. (A) 
Neutrophil numbers per high-power field were determined by MPO positivity (n = 4). (B) Representative MPO, Bcl-xL, and Siva1 sections from untreated 
WT and treated WT/Phd3–/– animals are shown; original magnification, ×400. (C) At higher magnification, cells with morphologic features of neutrophils 
are shown to stain for MPO, Bcl-xL, and Siva1; original magnification, ×1,000. (D) In situ apoptosis was shown with TUNEL staining, with MPO-positive 
TUNEL-positive neutrophils highlighted by black arrows and MPO-negative TUNEL-positive cells by the white arrow; original magnification, ×400.
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phils with respect to their functional and metabolic responses. In 
marked contrast to Hif-1α deficiency, in which myeloid cells dis-
play a profound impairment in aggregation, motility, invasiveness, 
and bacterial killing (4), Phd3-null neutrophils maintain normal 
in vitro chemotactic, phagocytic, and respiratory burst activity to 
both chemokine and bacterial stimuli. This is seen on the back-
ground of preserved intracellular ATP and glucose concentrations 
and again contrasts with the dramatic loss of intracellular ATP 
pools in Hif-1α–deficient cells (4). Indeed, the independence of 
the PHD3-selective phenotype from HIF regulation is further indi-
cated by the maintenance of WT Hif target gene transcriptional 
responses in the Phd3-null neutrophils. Conversely, it is possible 
the Hif1a–/– apoptosis phenotype, which we previously described 
(2), may in part be explained by loss of Phd3, since Hif1a–/– neutro-
phils showed reduced Phd3 expression in hypoxia. However, given 
the profound nature of the metabolic dysregulation in myeloid 
cells lacking Hif-1α, it is likely that ATP deficiency itself may also 
impact on the ability of these cells to remain viable, a response we 
would predict to occur independently of Phd3 regulation.
It is currently unclear whether the role of PHD3 in regulating 
hypoxic neutrophil survival is dependent upon its catalytic activ-
ity, since noncatalytic effects of PHDs have been described (9). It is 
also unclear whether the effect requires ongoing PHD3 activity in 
hypoxia or reflects the persistence of a biological effect of PHD3 in 
normoxia that “programs” the neutrophil for subsequent survival 
in hypoxia. The ability of PHD enzymes to retain activity at low oxy-
gen levels has certainly been described, with loss of PHD-mediated 
HIF transcriptional activity in glioblastoma cell lines reported at 
pO2 levels of 1% by Henze et al. (36) and persistent hydroxylation of 
recombinant HIF proteins and HIF ODDD constructs also shown 
under physiological oxygen tensions (9).
The downstream mechanism(s) by which PHD3 regulates hypoxic 
survival are clearly of great interest. In neuronal progenitor cells, 
Schlisio et al. identified PHD3-dependent regulation of KIF-1Bβ 
to modulate neuronal cell apoptosis following growth factor with-
drawal, with KIF-1Bβ both necessary and sufficient for neuronal 
apoptosis (11). We, however, have found no change in Kif-1bβ pro-
tein expression in murine bone marrow–derived neutrophils fol-
lowing aging or hypoxia. Moreover, neutrophils express a converse 
apoptotic phenotype in the absence of Phd3, with hypoxia being a 
profound survival stimulus in contrast to its effects on other prima-
ry cells. In superior cervical ganglion cells isolated from Phd3–/– mice, 
Bishop et al. originally described a reduction in apoptosis, again in 
contrast to our observed restoration of constitutive rates of apop-
tosis in the absence of Phd3, which was associated with an increase 
in cell number within the ganglion as well as in the adrenal medulla 
and carotid body (21). The subsequent heterozygous inactivation of 
Hif1a and Hif2a in explanted Phd3–/– neurons demonstrated an HIF-2 
dependence of this survival response. More recently, Henze et al. 
described the hypoxic induction of PHD2 and PHD3 to protect glio-
blastoma cell lines from hypoxia-induced cell death, with PHD inhi-
bition enhancing staurosporine- and TNF-mediated apoptosis (36). 
They conclude the biological function of PHDs within this system 
is exerted through the negative feedback on both HIF-1 and HIF2 
protein stability. Of note, we found no evidence for modulation of 
Hif transcriptional activity in Phd3-deficient neutrophils, compared 
with WT controls, either by whole mouse genome Affymetrix array 
or subsequently by TaqMan time courses of expression for recog-
nized Hif-1 and Hif-2 target genes. It would seem highly likely, 
therefore, that individual cell types have adapted unique hypoxic 
survival mechanisms and that the PHD3 target for hypoxic regula-
tion of neutrophil survival will be specific to the neutrophil.
In neutrophils we showed that PHD3-dependent hypoxic survival 
is associated with altered expression of SIVA1, a known proapop-
totic protein originally identified as a molecule interacting with the 
cytoplasmic portion of a TNF receptor family member CD27 (34). 
There is a previous report of SIVA1 expression in neutrophils (37), 
but no modulation of SIVA1 by hypoxia has been described in any 
cell type. SIVA1 interacts with BCL-XL, and this binding interac-
tion is likely unique for BCL-XL among BCL-2 proteins, although 
other non–BCL-2 family binding partners of this protein have been 
described (24). SIVA1 has been shown in vitro to sensitize cancer 
cell lines to UV-induced apoptosis through this ability to bind to 
and sequester BCL-XL (24), and we therefore postulate the interac-
tion between SIVA1 and BCL-XL represents an important step in the 
regulation of PHD3-dependent hypoxic neutrophil survival. While 
a role for BCL-XL in regulating hypoxic survival has not previously 
been studied, we show that BCL-XL is induced by hypoxia and that 
inhibition of BCL-XL by a BH3 mimetic abrogates hypoxic survival 
of neutrophils. Interestingly, Bcl-xL was not identified as being sig-
nificantly downregulated in Phd3–/– neutrophils in our Affymetrix 
array. However, Bcl-xL mRNA is stably expressed in murine neutro-
phils and unaltered by a range of inflammatory mediators (25). 
Moreover, Bcl-xL protein expression in other cell types is predomi-
nantly mediated by posttranslational mechanisms (38), although 
the direct hydroxylation of Bcl-xL is not currently reported. Thus, 
Figure 7
The roles of HIF-1 and PHD3 in regulating neutrophilic inflammation. 
HIF-1α expression is induced in neutrophils in hypoxia and positively 
regulates neutrophil metabolic function (glycolysis, ATP generation), 
cytokine and inflammatory mediator generation, and survival. HIF-1α 
extends neutrophil survival in hypoxia, with NF-κB, a known regula-
tor of neutrophil proinflammatory function, implicated in this response. 
However, hypoxic neutrophil survival requires PHD3, which itself reg-
ulates neutrophil survival downstream of HIF-1α, in association with 
upregulation of BCL-XL and downregulation of SIVA1. PHD3 does 
not directly modify neutrophil metabolic or proinflammatory functions. 
PHD3 therefore demonstrates an increased selectivity in the regulation 
of neutrophil lifespan compared with HIF-1α.
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alterations in proteins known or predicted to influence rates of 
neutrophil apoptosis are observed in Phd3–/– neutrophils, support-
ing the observed morphologic phenotype of apoptosis. Our experi-
ments support a role for SIVA1/BCL-XL in PHD3-mediated neutro-
phil survival, but the mechanism by which PHD3 modifies these 
proteins will require further study. Identification of novel targets of 
2-oxoglutarate–dependent dioxygenases with functional biological 
consequences is currently a significant challenge in the field. A sum-
mary of the potential interactions between BCL-XL/SIVA1- and HIF-
1α–associated pro-survival and antimicrobial pathways in PHD3-
dependent hypoxic neutrophil survival is provided in Figure 7. 
Not only does this highlight the complexity and degree of potential 
crosstalk between these proinflammatory responses, it emphasizes 
the selectivity of PHD3 loss for neutrophil survival, in marked con-
trast to the HIF-1α/NF-κB pathways, which have broad links to 
many key antimicrobial responses.
While our in vitro data provide important mechanistic insights into 
the PHD3-dependent regulation of hypoxic neutrophil survival, it is 
clearly important to establish whether this translates to a discernible 
antiinflammatory phenotype in vivo. To this end we investigated two 
independent models of neutrophilic inflammation where hypoxia 
has either been experimentally induced or is a recognized feature of 
the inflammatory process. Acute lung injury is widely recognized to 
be associated with a profound reduction in circulating oxygen ten-
sions and poor clinical outcomes in patients within the intensive care 
setting. In a murine model of acute lung injury, we demonstrated a 
significant reduction in neutrophilic inflammation in hypoxic Phd3–/– 
animals, which correlated with an increase in neutrophil apoptosis, 
both confirming our in vitro phenotype and supporting the impor-
tance of a selective loss of hypoxic neutrophil survival in a disease 
process in vivo. This reduced inflammation occurred in the absence 
of a difference in rates of neutrophil recruitment between WT and 
Phd3–/– animals, at a time point when such differences are typically 
apparent if there is a recruitment phenotype (31, 32). This is impor-
tant both to rule out altered neutrophil migration (which was not 
observed in vitro) but also because, in these whole animal knockouts, 
PHD3 deficiency of resident cells such as epithelial and endothelial 
cells could have modified neutrophil influx into the lungs. Murine 
DSS-induced colitis is also recognized to be profoundly hypoxic (35) 
and can be characterized histologically by neutrophil-predominant 
inflammation within the intestinal mucosa, although the specific 
role neutrophils play in the disease pathogenesis is unclear. In keep-
ing with a reduction in neutrophil-dominant pulmonary inflamma-
tion and increased neutrophil apoptosis, we again saw a reduction 
in neutrophil numbers in the intestinal mucosa of Phd3–/– animals 
compared with WT controls. Moreover, disease development and 
susceptibility in this model again do not differ between WT and 
Phd3–/– animals, as evidenced by daily weight and symptom score 
monitoring in this model up to day 6 (39). Thus, in two discrete mod-
els of acute neutrophilic inflammation, loss of PHD3 in a hypoxic 
setting resulted in the modulation of the end disease phenotype with 
enhanced inflammation resolution.
In summary, we identify PHD3 as a selective regulator of neutro-
phil hypoxic survival, and identify the transcriptional regulation of 
PHD3 in circulating neutrophils from individuals with rheumatoid 
arthritis. We describe the preservation of key antimicrobial func-
tions in Phd3–/– cells and thus dissociate the Phd3–/– neutrophil phe-
notype from the previously described broader Hif1a–/– phenotype 
with its critical defects in effective host defense, and further postu-
late that PHD3 itself may mediate neutrophil survival downstream 
of HIF-1α. Importantly, we confirm the importance of PHD3 regu-
lation of hypoxic neutrophil survival in vivo in both an acute lung 
injury model and a DSS model of colitis. Consequently, we pro-
pose the selective inhibition of PHD3 may provide a more potent 
and less toxic antiinflammatory strategy for targeting neutrophilic 
inflammation, an unmet clinical need with respect to a broad range 
of both acute and chronic inflammatory disease states.
Methods
For cell count determination, murine neutrophil glucose and ATP assays, 
and apoptosis assays, see Supplemental Methods.
Isolation and culture of neutrophils from healthy human volunteers and knockout 
mice. Human peripheral blood neutrophils were isolated from individu-
als with active rheumatoid arthritis, in accordance with 1987 American 
Rheumatism Association criteria (40), and with one or more swollen joints 
and from healthy volunteers using dextran sedimentation and discontinu-
ous plasma-Percoll gradients (41). Ethical approval was obtained from 
the South Sheffield Research Ethics Committee, and all participants gave 
written informed consent in accordance with the Declaration of Helsinki 
principles. Murine bone marrow–derived neutrophils were isolated using 
modified discontinuous HBSS-Percoll gradients (82%, 62%, and 51%) and 
peripheral blood neutrophils by negative magnetic selection following a ter-
minal inferior vena cava bleed into a 23 gauge pre-heparinized needle (42). 
Cell purity, assessed by cytospin, was routinely greater than 97% human 
peripheral blood, greater than 70% murine bone marrow, and greater than 
80% murine peripheral blood.
Purified cells were resuspended at 5 × 106/ml (human peripheral blood 
and murine bone marrow–derived neutrophils) or 1 × 106/ml (murine 
peripheral blood neutrophils) in RPMI with 10% fetal calf serum and 
50 U/ml streptomycin and penicillin. Cells were cultured in the presence 
or absence of peptidoglycan (10 μg/ml), E. coli LPS (100 ng/ml), GM-CSF 
(500 U/ml), or ABT-737 (10 μM) (Selleck Chemicals) in normoxia (19 kPa) 
or hypoxia (3 kPa) and apoptosis determined by cytospin morphology. 
Hypoxia was achieved using an in vivo 400 hypoxic work station (Ruskinn) 
with a 5% CO2/balance N2 gas mix preset to deliver an oxygen tension of 
0.75 kPa into the chamber, which correlated with a culture media oxygen 
tension of 3 kPa as determined by automated blood gas analysis (NPT7, 
Radiometer). All media were allowed to equilibrate overnight prior to use.
Animals. Phd3–/–, myeloid-targeted Hif1a–/–, and WT mice were used in 
these experiments and have previously been described (4, 21). Phd3–/– mice 
were initially on a mixed Swiss/129SvEv genetic background, generated 
through heterozygous cross, with mice from the same litter used for com-
parison. For functional assays Phd3–/– mice backcrossed onto a C57BL/6 
background were subsequently used. All key results presented were con-
firmed in this background (data not shown). Lysozyme M–driven Cre 
(lysMcre) was used to target Hif1a deletions to myeloid lineage cells (4) 
with animals also backcrossed to a C57BL/6 background. All animal 
experiments were conducted in accordance with the Home Office Animals 
(Scientific Procedures) Act of 1986, with approval of the Sheffield Ethical 
Review Committee, Sheffield, United Kingdom.
Immunoblot detection of human and murine neutrophil protein. Whole cell 
lysates were prepared by resuspending 0.5 × 106 murine neutrophils in 
30 μl SDS lysis buffer or 10 × 106 human neutrophils in 100 μl hypotonic 
lysis buffer (10 mM Tris-HCl, pH 7.8, 1.5 mM EDTA, 10 mM KCl, 0.5 mM 
DTT, 1 mM sodium orthovanadate, 2 mM levamisole, 0.5 mM benzamidine, 
and 0.05% NP40 and complete protease inhibitor cocktail [Roche Applied 
Science]), sonication lysing (30 seconds on, 30 seconds off) (Bioruptor, 
Diagenode), and boiling in 100 μl 2× SDS buffer with 1 × 106 to 5 × 106 neu-
trophils loaded per lane. Protein recovery was assessed by immunoblotting 
with primary antibodies against PHD1–3 (generated by our research team), 
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SIVA1 (clone M-175, Santa Cruz Biotechnology Inc.), and Bcl-xL (clone aa 
18–233, Santa Cruz Biotechnology Inc.). Sample loading was confirmed by 
β-actin or P38 expression. All bands shown were at the predicted molecular 
weight for the protein of interest.
Human RNA isolation and relative quantification. Neutrophils (20 × 106/con-
dition) were lysed with 2 ml TRI Reagent (Sigma-Aldrich), and RNA was 
extracted using chloroform phase partitioning and isopropanol. Samples 
were DNase digested and random hexamer cDNA synthesized by reverse 
transcription, with cDNA run in TaqMan assays at a final concentration of 
100 ng/μl. Assays-On-Demand gene expression TaqMan MGB 6FAM dye–
labeled products (Applied Biosystems) were used for GAPDH and β-actin 
and assays performed according to the manufacturer’s instructions. 6FAM 
dye–labeled probes and primers were designed for PHD1 (sense 5′-AGC-
GGGCAGCAGCCAAAGACAAG-3′, antisense 5′-TGCCATGCGGCTCT-
GGGACTG-3′, probe 5′-ATCAGCTAGCATCAGGACAGAAAGGTGTCC-3′), 
PHD2 (sense 5′-AGCCCGGCTGCGAAACCATTG-3′, antisense 5′-TTC-
GTCCGGCCATTGATTTTGT-3′, probe 5′-GCTGCTCATGAGCAGCAT-
GGACGACC-3′), PHD3 (sense 5′-AGTCCGGAAACGGGTCGTGGAG-3′, 
antisense 5′-AGCGTCGGGGACAAGGGAAAGTT-3′, probe 5′-TCCGCAC-
CACTCCCGCTGGTTCCCGAAG-3′). Relative quantification for each gene 
was determined against β-actin expression.
Murine neutrophil functional assays. For chemotaxis assays, neutrophil 
chemotaxis to KC (0–1 mM) over 3 hours was measured using normoxia/
hypoxia pre-equilibrated Neuro Probe ChemoTx microplates with a 5-μm 
filter. The number of cells in each well was expressed as a percentage of 
the positive control minus the percent migration of the chemokinesis con-
trol. For phagocytosis assays, following a 1 hour pre-equilibration of neu-
trophils (1 × 106/ml) in either normoxia or hypoxia, neutrophil uptake of 
Alexa Fluor 488–labeled heat-inactivated E. coli after 30 minutes coculture 
(MOI of 1:1) was determined by flow cytometry (FACSCalibur, BD). For 
respiratory burst assays, following a 1 hour pre-equilibration of neutrophils 
(1 × 106/ml) in either normoxia or hypoxia, cells were cultured with 6 mM 
DCF for 30 minutes and then stimulated for a further 30 minutes with 
heat-inactivated E. coli at an MOI of 10:1 (E. coli/PMN) before FL1 geometric 
mean fluorescence was determined by flow cytometry.
Murine RNA isolation and relative quantification. Neutrophils (1 × 106/condi-
tion) were lysed and RNA extracted using the mirVana total RNA isolation 
protocol (Ambion). Samples were DNase digested, and biotin-labeled anti-
sense RNA was prepared for array analysis using the Affymetrix one cycle 
target labeling method as per the manufacturer’s instructions. Fragmented 
antisense RNA (15 μg) was applied to each array chip following determination 
of integrity by Agilent Bioanalysis (Agilent Technologies). Affymetrix data were 
normalized and log fold change was determined using PANTHER software 
(http://www.pantherdb.org/). Microarray data were deposited in the MIAME-
compliant GEO database (accession number GSE26023). For TaqMan quan-
titative PCR, random hexamer cDNA was synthesized by reverse transcription 
and run at a final concentration of 100 ng/μl. Assays-On-Demand gene expres-
sion TaqMan MGB 6FAM dye–labeled products (Applied Biosystems) were 
used for Phd1, Phd2, Phd3, Vegf, Glut1, Pai1, Bcl-xL, Kc, Gapdh, Siva1, and β-actin 
and assays performed according to the manufacturer’s instructions. 6FAM 
dye–labeled probes and primers were designed for Nf-κb (sense 5′-GGCG-
GCACGTTTTACTCTTT-3′, antisense 5′-CCGTCTCCAGGAGGTTAATGC-
3′, probe 5′-CGCTTTCGGAGGTGCTTTCGCAG-3′), Ikk (sense 5′-TGCA-
CACCGTGCAGAGTCA-3′, antisense 5′-TGCTTGCAGCCCAACAACT-3′, 
probe 5′-CGTGTTCTCAAGGAGCTGTTTGGTCACC-3′), and I-κb (sense 
5′-CGGAGGACGGAGACTCGTT-3′, antisense 5′-CTTCCATGGTCAGCG-
GCTT-3′, probe 5′-TGCACTTGGCAATCATCCACGAAGA-3′). Relative quan-
tification for each gene was determined against β-actin expression. Murine LPS 
acute lung injury model. Direct tracheal instillation of bacterial LPS (0.3 mg) was 
performed on anesthetized mice (28), and the animals recovered for 6 hours 
in a warmed cage in room air. At this point, after placement in a sealed work 
station (Wolf Laboratories) set to 21% O2, mice were maintained either at 21% 
for the duration of the experiment or, following reduction of O2 to 10% over 
1 hour, at 10% O2 for the rest of the experiment. For 6-hour recruitment data, 
3 mg nebulized LPS was instilled without a requirement for anesthesia, and 
animals were maintained at 21% for 6 hours. At the end time point, mice were 
sacrificed (30), the trachea re-cannulated, and the lungs instilled with 3.5 ml 
ice-cold PBS in 0.5- to 1.0-ml aliquots. The recovered lavage fluid was main-
tained on ice. Hemocytometer counts were determined, and then samples were 
divided into 2 aliquots, pelleted (1,000 g, 5 minutes, 4°C), and resuspended in 
either fetal calf serum or 1% paraformaldehyde prior to cytocentrifugation. 
Cytospins of serum-suspended cells were stained by Diff-Quick for differen-
tial cell counts and morphologic scoring of apoptosis, and paraformaldehyde-
suspended cytospins stored at 4°C for subsequent analysis of apoptosis by 
deoxynucleotidyltransferase-mediated TUNEL. TUNEL was performed using 
an ApopTag Peroxidase In Situ Apoptosis Detection Kit (Chemicon Interna-
tional) as per the manufacturer’s instructions.
For histological sections, unlavaged lungs were fixed via the trachea 
with 10% buffered formalin at 20 cm H2O and paraffin-embedded blocks 
prepared. Serial sections were subsequently stained with hematoxylin and 
eosin or anti-MPO antibody (clone ab15484, Abcam), anti–Bcl-xL antibody 
(BD Biosciences — Transduction Laboratories), or anti-SIVA1 antibody 
(clone M-175, Santa Cruz Biotechnology Inc.) following deparaffinization. 
Neutrophil count per high-power field was calculated from the individual 
counts of 5 high-power fields per section.
Murine DSS-induced acute colitis model. Colitis was induced using a previ-
ously described method (35), and mice were sacrificed at 6 days. Sections of 
intestine were stained with hematoxylin and eosin or anti-MPO, anti–Bcl-xL, 
or anti-Siva1 antibodies (as above) following deparaffinization. Total neu-
trophils per high-power field were calculated from the individual counts of 
5 high power-fields per section. TUNEL was performed using an ApopTag 
Peroxidase In Situ Apoptosis Detection Kit (Chemicon International) as 
per the manufacturer’s instructions.
Statistics. Gene array data were analyzed for statistical significance after 
normalization using PANTHER software. For all other experiments, where 
data allowed, significance was determined by paired 2-tailed t tests unless 
otherwise specified, with P values less than 0.05 considered significant. 
Data are expressed as mean ± SEM. 
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